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A retraction of the Original Research Article
Mechanism of Action of the Novel Nickel(II) Complex in Simultaneous Reactivation of the
Apoptotic Signaling Networks Against Human Colon Cancer Cells
by Samie, N., Haerian, B. S., Muniandy, S., Marlina, A., Kanthimathi, M. S., Abdullah, N. B., et al.
(2016). Front. Pharmacol. 6:313. doi: 10.3389/fphar.2015.00313
The Journal and Authors retract the 28 January 2016 article cited above for the following reasons:
Following online criticisms of the published paper, an investigation at the journal has confirmed
the manipulation and duplication of data, and a level of image processing that is not compliant
with the journal’s policies on image data integrity.
Further, a post-publication cross-check screening revealed significant overlap with another
manuscript submitted by the authors to another journal. While all manuscripts submitted to
Frontiers undergo cross-check screening, the article cited below was in review in parallel with the
Frontiers article and thus the overlap was not apparent until publication (Samie et al., 2016).
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